| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.065 | 0.8 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.8 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |